Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $crdf

Cardiff Oncology announces positive clinical data from an investigator-sponsored trial for Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025, leading to a notable price increase.

### About $crdf
Cardiff Oncology (CRDF) is a biotechnology company focused on developing novel cancer therapies.  

### Insights
- $crdf creators is up XXXXXX% from the previous month.
- $crdf engagements is up XXXXXX% from the previous week.
- $crdf mentions is up XXXXXX% from the previous month.

### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$crdf/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$crdf/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXX  
X Week: XXXXX +144%  
X Month: XXXXXX -XXXX%  
X Months: XXXXXXXXX +99%  
X Year: XXXXXXXXX +110%  
1-Year High: XXXXXXX on 2025-07-29  
1-Year Low: XX on 2025-11-16  

Engagements by network (24h):
Reddit: X
X: XXXXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$crdf/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$crdf/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XXX +126%  
X Month: XXX +195%  
X Months: XXXXX +367%  
X Year: XXXXX +15%  
1-Year High: XXXXX on 2025-07-10  
1-Year Low: X on 2025-10-20  

Mentions by network (24h):
Reddit: X
X: XXX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$crdf/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$crdf/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $crdf in the last XX hours which is down XXXX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX +64%  
X Month: XXX +112%  
X Months: XXXXX +699%  
X Year: XXXXX -XX%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-10-20  

The most influential creators that mention $crdf in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XXXXX       |
| [@JolieRosy96450](/creator/twitter/JolieRosy96450)   | X    | XX        | X     | X           |
| [@RosaJim94865433](/creator/twitter/RosaJim94865433) | X    | XXX       | X     | X           |
| [@Brittan48189818](/creator/twitter/Brittan48189818) | X    | XXX       | X     | X           |
| [@KaffelDr](/creator/twitter/KaffelDr)               | X    | XX        | X     | X           |
| [@Beverly97739735](/creator/twitter/Beverly97739735) | X    | XXX       | X     | X           |
| [@WrightWhit84274](/creator/twitter/WrightWhit84274) | X    | XX        | X     | X           |
| [@Stock_Marketr12](/creator/twitter/Stock_Marketr12) | X    | XXX       | X     | X           |
| [@Lola_La_Fleur_](/creator/twitter/Lola_La_Fleur_)   | X    | XX        | X     | X           |
| [@Stock_Analysis2](/creator/twitter/Stock_Analysis2) | XX   | XXX       | X     | X           |

[View More](/list/creators/$crdf/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$crdf/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$crdf/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -XX%  
X Month: XXX% no change  
X Months: XXX% no change  
X Year: XXX% +2%  
1-Year High: XXX% on 2024-12-24  
1-Year Low: X% on 2025-11-24  

Most Supportive Themes:
- Engagement Surge: (75%) There has been a significant increase in user engagement with CRDF, indicating growing interest and discussion around the company's developments.
- Content Creation Increase: (20%) The number of posts about CRDF has doubled, suggesting a heightened level of activity and information sharing within the social media sphere.
  
Most Critical Themes:
  

### Top $crdf Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"📌 Biotech Stock News 12/9 @ Open $XCUR XX% Burixafor Topline Data @ ASH'25 $WVE X% $250M Public Offering $TERN X% TERN-701 Ph1 Data; $400M Public Offering $ASMB X% ABI-1179 & ABI-5366 Interim Results $CRDF X% Onvansertib Data @ ASH'25 $ATOS X% Endoxifen U.S. Patent $GPCR X% $500M Public Offering $COYA X% Patients Dosed in ALSTARS Trial $TEVA X% Submits NDA for Olanzapine $ALC X% Amended Merger Agreement $JNJ X% Ph3 study supports new treatment $CTXR X% $18M Offering & Placement $OSTX X% OST-HER2 pre-Marketing Authorisation Mtg $CRIS X% Updated Data from Frontline AML Study $INCY 0%"  
[X Link](https://x.com/BiopharmIQ/status/1998789058378739986) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-12-10T16:17Z 28.1K followers, 2432 engagements


"🗓 Watchlist for Wed Dec XX $CGNT $BRZE $GNSS $LPTH $VELO $CRDF $TPG $INR 📌 See pinned tweet for how I use my WL"  
[X Link](https://x.com/MinervaCap/status/1998612169815203908) [@MinervaCap](/creator/x/MinervaCap) 2025-12-10T04:34Z 1935 followers, XXX engagements


"$CRDF +10.61% today as Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025 More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1998141281554293084) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-12-08T21:22Z 3009 followers, XXX engagements


"$CRDF Results from Investigator-led (not company) Trial Positive monotherapy results yet the future will likely focus on use in combo treatment"  
[X Link](https://x.com/AscendingBio/status/1998140368039329995) [@AscendingBio](/creator/x/AscendingBio) 2025-12-08T21:19Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$crdf

Cardiff Oncology announces positive clinical data from an investigator-sponsored trial for Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025, leading to a notable price increase.

About $crdf

Cardiff Oncology (CRDF) is a biotechnology company focused on developing novel cancer therapies.

Insights

  • $crdf creators is up XXXXXX% from the previous month.
  • $crdf engagements is up XXXXXX% from the previous week.
  • $crdf mentions is up XXXXXX% from the previous month.

Engagements: XXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX +144%
X Month: XXXXXX -XXXX%
X Months: XXXXXXXXX +99%
X Year: XXXXXXXXX +110%
1-Year High: XXXXXXX on 2025-07-29
1-Year Low: XX on 2025-11-16

Engagements by network (24h): Reddit: X X: XXXXX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX +126%
X Month: XXX +195%
X Months: XXXXX +367%
X Year: XXXXX +15%
1-Year High: XXXXX on 2025-07-10
1-Year Low: X on 2025-10-20

Mentions by network (24h): Reddit: X X: XXX

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $crdf in the last XX hours which is down XXXX% from XX in the previous XX hours Daily Average: XX
X Week: XX +64%
X Month: XXX +112%
X Months: XXXXX +699%
X Year: XXXXX -XX%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-10-20

The most influential creators that mention $crdf in the last XX hours

Creator Rank Followers Posts Engagements
@BiopharmIQ X XXXXXX X XXXXX
@JolieRosy96450 X XX X X
@RosaJim94865433 X XXX X X
@Brittan48189818 X XXX X X
@KaffelDr X XX X X
@Beverly97739735 X XXX X X
@WrightWhit84274 X XX X X
@Stock_Marketr12 X XXX X X
@Lola_La_Fleur_ X XX X X
@Stock_Analysis2 XX XXX X X

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XXX% no change
X Months: XXX% no change
X Year: XXX% +2%
1-Year High: XXX% on 2024-12-24
1-Year Low: X% on 2025-11-24

Most Supportive Themes:

  • Engagement Surge: (75%) There has been a significant increase in user engagement with CRDF, indicating growing interest and discussion around the company's developments.
  • Content Creation Increase: (20%) The number of posts about CRDF has doubled, suggesting a heightened level of activity and information sharing within the social media sphere.

Most Critical Themes:

Top $crdf Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"📌 Biotech Stock News 12/9 @ Open $XCUR XX% Burixafor Topline Data @ ASH'25 $WVE X% $250M Public Offering $TERN X% TERN-701 Ph1 Data; $400M Public Offering $ASMB X% ABI-1179 & ABI-5366 Interim Results $CRDF X% Onvansertib Data @ ASH'25 $ATOS X% Endoxifen U.S. Patent $GPCR X% $500M Public Offering $COYA X% Patients Dosed in ALSTARS Trial $TEVA X% Submits NDA for Olanzapine $ALC X% Amended Merger Agreement $JNJ X% Ph3 study supports new treatment $CTXR X% $18M Offering & Placement $OSTX X% OST-HER2 pre-Marketing Authorisation Mtg $CRIS X% Updated Data from Frontline AML Study $INCY 0%"
X Link @BiopharmIQ 2025-12-10T16:17Z 28.1K followers, 2432 engagements

"🗓 Watchlist for Wed Dec XX $CGNT $BRZE $GNSS $LPTH $VELO $CRDF $TPG $INR 📌 See pinned tweet for how I use my WL"
X Link @MinervaCap 2025-12-10T04:34Z 1935 followers, XXX engagements

"$CRDF +10.61% today as Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025 More Info:"
X Link @OzmosiHealth 2025-12-08T21:22Z 3009 followers, XXX engagements

"$CRDF Results from Investigator-led (not company) Trial Positive monotherapy results yet the future will likely focus on use in combo treatment"
X Link @AscendingBio 2025-12-08T21:19Z XXX followers, XXX engagements

$crdf
/topic/$crdf